.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Medtronic
McKinsey
Dow
McKesson
Argus Health
Teva
Boehringer Ingelheim
QuintilesIMS
Johnson and Johnson

Generated: July 26, 2017

DrugPatentWatch Database Preview

DESONIDE Drug Profile

« Back to Dashboard

Which patents cover Desonide, and when can generic versions of Desonide launch?

Desonide is a drug marketed by Perrigo New York, G And W Labs Inc, Hi-tech Pharmacal, Taro, Fougera Pharms, and Taro Pharm. and is included in nine NDAs.

The generic ingredient in DESONIDE is desonide. There are twenty-nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desonide profile page.

Summary for Tradename: DESONIDE

Patents:0
Applicants:6
NDAs:9
Suppliers / Packagers: see list8
Bulk Api Vendors: see list26
Clinical Trials: see list5
Patent Applications: see list4,258
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DESONIDE at DailyMed

Pharmacology for Tradename: DESONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York
DESONIDE
desonide
CREAM;TOPICAL017010-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Taro
DESONIDE
desonide
OINTMENT;TOPICAL074254-001Aug 3, 1994ABRXNoNo► Subscribe► Subscribe► Subscribe
Hi-tech Pharmacal
DESONIDE
desonide
OINTMENT;TOPICAL208836-001Mar 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
DESONIDE
desonide
LOTION;TOPICAL075860-001Mar 19, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
DESONIDE
desonide
OINTMENT;TOPICAL017426-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Mallinckrodt
Harvard Business School
Novartis
Federal Trade Commission
Julphar
Argus Health
Medtronic
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot